We are live on ! Find out more
UPH.WS

UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS

Delisted

UPH.WS was delisted on the 27th of November, 2023.

Back to rankings

1 hedge funds and large institutions have $62 invested in UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $55 → $62 (+$7)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

UPH.WS Hedge Fund Activity: Q1 2024 in Review

1 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share (UPH.WS) for Q1 2024, worth a combined $62 — up 13% from $55 a quarter earlier.

Fund positioning in UPH.WS was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share (UPH.WS) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $62 of UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share stock for Q1 2024, up 13% quarter-over-quarter.
  • 0 funds opened new UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share positions in Q1 2024 and 0 closed out.

Based on aggregated 13F filings for Q1 2024.